搜索筛选:
搜索耗时0.4204秒,为你在为你在102,267,441篇论文里面共找到 3 篇相符的论文内容
发布年度:
Phase 1 studies comparing safety, tolerability, pharmacokinetics and pharmacodynamics of HLX01(a rit
[期刊论文] 作者：Yuankai Shi,Qingyuan Zhang,Xiaohong Han,Yan Qin,Xiaoyan Ke,Hang Su,Li Liu,Jinxiang Fu,Jie Jin,Jifeng Feng,
来源：中国癌症研究:英文版 年份：2021
Objective: This study aimed to compare the pharmacokinetic, pharmacodynamic and safety profiles of HLX01(a rituximab biosimilar) and reference rituximab sourced from China(Mab Thera?;rituximab-CN).Methods: Here we report the results of two ......
The relationship between treatment-induced hypertension and efficacy of anlotinib in recurrent or me
[期刊论文] 作者：Yan Song,Juxiang Xiao,Wentao Fang,Ping Lu,Qingxia Fan,Yongqian Shu,Jifeng Feng,Shu Zhang,Yi Ba,Yang Zhao,
来源：癌症生物学与医学:英文版 年份：2021
Objective:In this post-hoc analysis,we evaluated anlotinib treatment-induced hypertension as a potential predictive factor of efficacy in esophageal squamous cell carcinoma(ESCC)patients.Methods:A total of 109 patients enrolled in the anlot......
The relationship between treatment-induced hypertension and efficacy of anlotinib in recurrent or me
[期刊论文] 作者：Yan Song,Juxiang Xiao,Wentao Fang,Ping Lu,Qingxia Fan,Yongqian Shu,Jifeng Feng,Shu Zhang,Yi Ba,Yang Zhao,
来源：癌症生物学与医学（英文版） 年份：2021
Objective:In this post-hoc analysis, we evaluated anlotinib treatment-induced hypertension as a potential predictive factor of efficacy in esophageal squamous c...
相关搜索：
